When you have type 1 diabetes and obesity, you're really challenged, because insulin resistance is more pronounced when you have overweight on board as well, but it's also a lot more difficult to control and have good glucose control. And that was actually what was very much in the focus in the joint symposium of the ECO and the EASD. My name is Tina Vilsbøll. I'm a professor at the University of Copenhagen in Denmark, and I'm also the Honorary Secretary of the EASD. Right now, I'm in Málaga. I'm at the ECO, which is a conference arranged by the EASO. We are around 4,000 people focusing on all the really interesting data related to overweight and obesity but also with diabetes on board. At the ECO, but also at the EASD, we have what we call “joint symposiums”, which are symposiums that are arranged with the EASD and the EASO together. And I just had a huge honour to chair the symposium together with Barbara McGowan from the EASO. And we decided this year at the ECO that the title of the symposium should be “The lifestory of type 1 diabetes and obesity.” First, we had a talk related to pregnancy, but the speaker actually took it a little bit before pregnancy, focusing on all the challenges that overweight and obesity do give, actually both in individuals with type 1 diabetes but also type 2 diabetes. Then we had Julie Kloppenborg, a Danish paediatrician, talk about childhood obesity when combined with type 1 diabetes. Huge challenges. More and more young children become overweight and are challenged with increased insulin need and also stigma and life complications overall. And then finally we had a talk about type 1 diabetes and obesity and elderly people. Individuals with obesity with diabetes, they live longer. Often, they're challenged by polypharmacy, they have complicated devices that they might even not know how to take care of. Really good overview and interesting conference. As you know, in the EASD, we have very much focus on diabetes: type 1 diabetes, type 2 diabetes, gestational diabetes, monogenetic diabetes, and all the different types of diabetes. We also know that worldwide more and more individuals do unfortunately have an increase in weight. There are more and more that have overweight, obesity, and even in children as well. And if you have two chronic conditions or diseases, obesity is in some countries just a condition, in many countries it's also a disease, and when you have type 1 diabetes and obesity you are really challenged, because you need more insulin, you actually have huge fluctuation in your glucose profile. And individuals with type 1 diabetes are of course worried about complications, but it’s also a lot more difficult to control and have good glucose control when you struggle with two chronic diseases. I had a lot of fun, I learned a lot, and I really enjoyed the collaborative arrangement with EASO and the EASD, and just look forward to the EASD in Vienna coming up soon, because there we will also have a joint symposium with the EASO, but also with many other societies. And just look forward to it. I can tell you the programme will be really cool, with a lot of breaking trials. Looking forward to seeing you in Vienna.